Medication-info.com Search Menu

Boncresa (Denosumab): Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx) Boxed warning
Strength:
60 mg/mL
Other brand names:
Drug class:
Active ingredient:
Similar drugs:

Patient information: uses, side effects, how to take - Boncresa

What is the most important information I should know about Boncresa?

If you receive Boncresa, you should not receive other denosumab products at the same time.

Boncresa can cause serious side effects including:

  • Increased risk of severe low calcium levels in your blood (hypocalcemia). Boncresa may lower the calcium levels in your blood. If you have low blood calcium before you start receiving Boncresa, it may get worse during treatment. Your low blood calcium must be treated before you receive Boncresa. Talk to your doctor before starting Boncresa. Your doctor may prescribe calcium and vitamin D to help prevent low calcium levels in your blood while you take Boncresa. Take calcium and vitamin D as your doctor tells you to.

    If you have advanced chronic kidney disease (may or may not be on kidney dialysis), Boncresa may increase your risk for severe low calcium levels in your blood, which could result in hospitalization, life-threatening events and death. A mineral and bone disorder associated with kidney disease called chronic kidney disease-mineral bone disorder (CKD-MBD) may increase your risk for severe low calcium levels in blood. Before you start Boncresa and during treatment, your doctor may need to do certain blood tests to check for CKD-MBD.

    Most people with low blood calcium levels do not have symptoms, but some people may have symptoms. Call your doctor right away if you have symptoms of low blood calcium such as:

  • spasms, twitches, or cramps in your muscles
  • numbness or tingling in your fingers, toes, or around your mouth
  • Serious allergic reactions. Serious allergic reactions have happened in people who take denosumab products. Call your doctor or go to your nearest emergency room right away if you have any symptoms of a serious allergic reaction. Symptoms of a serious allergic reaction may include:

    • low blood pressure (hypotension)
    • rash
    • trouble breathing
    • itching
    • throat tightness
    • hives
    • swelling of your face, lips, or tongue
  • Severe jaw bone problems (osteonecrosis). Severe jaw bone problems may happen when you take Boncresa. Your doctor should examine your mouth before you start Boncresa. Your doctor may tell you to see your dentist before you start Boncresa. It is important for you to practice good mouth care during treatment with Boncresa. Ask your doctor or dentist about good mouth care if you have any questions.
  • Unusual thigh bone fractures. Some people have developed unusual fractures in their thigh bone. Symptoms of a fracture include new or unusual pain in your hip, groin, or thigh.
  • Increased risk of broken bones, including broken bones in the spine, after stopping, skipping or delaying Boncresa. Talk with your doctor before starting Boncresa treatment. After your treatment with Boncresa is stopped, or if you skip or delay taking a dose, your risk for breaking bones, including bones in your spine, is increased. Your risk for having more than 1 broken bone in your spine is increased if you have already had a broken bone in your spine. Do not stop, skip or delay taking Boncresa without first talking with your doctor. If your Boncresa treatment is stopped, talk to your doctor about other medicine that you can take.
  • Serious infections. Serious infections in your skin, lower stomach area (abdomen), bladder, or ear may happen if you take Boncresa. Inflammation of the inner lining of the heart (endocarditis) due to an infection also may happen more often in people who take Boncresa. You may need to go to the hospital for treatment if you develop an infection.

    Boncresa is a medicine that may affect the ability of your body to fight infections. People who have a weakened immune system or take medicines that affect the immune system may have an increased risk for developing serious infections. Call your doctor right away if you have any of the following symptoms of infection:

  • fever or chills
  • skin that looks red or swollen and is hot or tender to touch
  • fever, shortness of breath, cough that will not go away
  • severe abdominal pain
  • frequent or urgent need to urinate or burning feeling when you urinate
  • Skin problems. Skin problems such as inflammation of your skin (dermatitis), rash, and eczema may happen if you take Boncresa. Call your doctor if you have any of the following symptoms of skin problems that do not go away or get worse:

    • redness
    • your skin is dry or feels like leather
    • itching
    • blisters that ooze or become crusty
    • small bumps or patches (rash)
    • skin peeling
  • Bone, joint, or muscle pain. Some people who take denosumab products develop severe bone, joint, or muscle pain.

Call your doctor right away if you have any of these side effects.

What is Boncresa?

Boncresa is a prescription medicine used to:

  • Treat osteoporosis (thinning and weakening of bone) in women after menopause (“change of life”) who:

    • are at high risk for fracture (broken bone)
    • cannot use another osteoporosis medicine or other osteoporosis medicines did not work well
  • Increase bone mass in men with osteoporosis who are at high risk for fracture.
  • Treat osteoporosis in men and women who will be taking corticosteroid medicines (such as prednisone) for at least 6 months and are at high risk for fracture.
  • Treat bone loss in men who are at high risk for fracture receiving certain treatments for prostate cancer that has not spread to other parts of the body.
  • Treat bone loss in women who are at high risk for fracture receiving certain treatments for breast cancer that has not spread to other parts of the body.

It is not known if Boncresa is safe and effective in children. Boncresa is not approved for use in children.

Do not take Boncresa if you:

  • have been told by your doctor that your blood calcium level is too low.
  • are pregnant or plan to become pregnant.

  • are allergic to denosumab products or any of the ingredients in Boncresa. See the end of this Medication Guide for a complete list of ingredients in Boncresa.

Before taking Boncresa, tell your doctor about all of your medical conditions, including if you:

  • are taking other denosumab products.
  • have low blood calcium.
  • cannot take daily calcium and vitamin D.
  • had parathyroid or thyroid surgery (glands located in your neck).
  • have been told you have trouble absorbing minerals in your stomach or intestines (malabsorption syndrome).
  • have kidney problems or are on kidney dialysis.
  • are taking medicine that can lower your blood calcium levels.
  • plan to have dental surgery or teeth removed.
  • are pregnant or plan to become pregnant. Boncresa may harm your unborn baby.

Females who are able to become pregnant:

  • Your healthcare provider should do a pregnancy test before you start treatment with Boncresa.
  • You should use an effective method of birth control (contraception) during treatment with Boncresa and for at least 5 months after your last dose of Boncresa.
  • Tell your doctor right away if you become pregnant while taking Boncresa.
  • are breastfeeding or plan to breastfeed. It is not known if Boncresa passes into your breast milk. You and your doctor should decide if you will take Boncresa or breastfeed. You should not do both.

Tell your doctor about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

Know the medicines you take. Keep a list of medicines with you to show to your doctor or pharmacist when you get a new medicine.

How will I receive Boncresa?

  • Boncresa is an injection that will be given to you by a healthcare provider. Boncresa is injected under your skin (subcutaneous).
  • You will receive Boncresa 1 time every 6 months.
  • You should take calcium and vitamin D as your doctor tells you to while you receive Boncresa.
  • If you miss a dose of Boncresa, you should receive your injection as soon as you can.
  • Take good care of your teeth and gums while you receive Boncresa. Brush and floss your teeth regularly.
  • Tell your dentist that you are receiving Boncresa before you have dental work.

What are the possible side effects of Boncresa?

Boncresa may cause serious side effects.

  • See “What is the most important information I should know about Boncresa?”
  • It is not known if the use of Boncresa over a long period of time may cause slow healing of broken bones.

The most common side effects of Boncresa in women who are being treated for osteoporosis after menopause are:

  • back pain
  • muscle pain
  • pain in your arms and legs
  • bladder infection
  • high cholesterol

The most common side effects of Boncresa in men with osteoporosis are:

  • back pain
  • common cold (runny nose or sore throat)
  • joint pain

The most common side effects of Boncresa in patients with glucocorticoid-induced osteoporosis are:

  • back pain
  • lung infection (bronchitis)
  • high blood pressure
  • headache

The most common side effects of Boncresa in patients receiving certain treatments for prostate or breast cancer are:

  • joint pain
  • pain in your arms and legs
  • back pain
  • muscle pain

Tell your doctor if you have any side effect that bothers you or that does not go away.

These are not all the possible side effects of Boncresa.

Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

How should I store Boncresa if I need to pick it up from a pharmacy?

  • Keep Boncresa in a refrigerator at 36°F to 46°F (2°C to 8°C) in the original carton.
  • Do not freeze Boncresa.
  • When you remove Boncresa from the refrigerator, Boncresa must be kept at room temperature [up to 77°F (25°C)] in the original carton and must be used within 14 days.
  • Do not keep Boncresa at temperatures above 77°F (25°C). Warm temperatures will affect how Boncresa works.
  • Do not shake Boncresa.
  • Keep Boncresa in the original carton to protect from light.

Keep Boncresa and all medicines out of the reach of children.

General information about the safe and effective use of Boncresa.

Medicines are sometimes prescribed for purposes other than those listed in a Medication Guide. Do not use Boncresa for a condition for which it was not prescribed. Do not give Boncresa to other people, even if they have the same symptoms that you have. It may harm them. You can ask your doctor or pharmacist for information about Boncresa that is written for healthcare providers.

What are the ingredients in Boncresa?

Active ingredient: denosumab-mobz

Inactive ingredients: glacial acetic acid, polysorbate 20, sorbitol, Water for Injection (USP), and sodium hydroxide

Manufactured by:

Amneal Pharmaceuticals LLC

Piscataway, NJ 08854

Product of Spain

US License No. 2241

For more information, go to www.amneal.com or call Amneal Pharmaceuticals LLC at 1-877-835-5472.

This Medication Guide has been approved by the U.S. Food and Drug Administration. Revised: 09-2026-01

About this document

Source: FDA drug labeling via NLM DailyMed · Application number: BLA 761456 · View the label on DailyMed

Revision date stated in the text: September 2026

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Boncresa

Rx or OTC
Prescription (Rx)?
  • This drug is available only with a prescription from a licensed healthcare provider.
  • Rx
Boxed warning Yes – this drug has a boxed warning (also called a black box warning), the strongest warning of the FDA.
Drug class RANK Ligand Inhibitor
Active ingredient Denosumab 60 mg/mL
Dosage form Injection, solution
Route Subcutaneous
Marketing status not in the current FDA NDC Directory
Company (applicant) AMNEAL PHARMS LLC
FDA approval BLA 761456Biologics License Application (BLA) Approved December 19, 2025
Manufacturers 1 labelers list this drug on DailyMed
Packages (NDC)
Package
60 mg/mL – 1 ml in 1 syringe / 1 in 1 carton NDC 70121-2702-1

Source: FDA drug labeling via NLM DailyMed, data as of November 5, 2026. FDA data (DailyMed, Orange Book, Drug Shortages, enforcement reports). Not a substitute for the advice of a doctor or pharmacist.